0.04Open0.05Pre Close5 Volume124 Open Interest66.00Strike Price20.00Turnover73.09%IV9.06%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type-0.0281Delta0.0177Gamma1813.25Leverage Ratio-0.0388Theta-0.0001Rho-51.00Eff Leverage0.0032Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet